Skip to content

TMS Alteration of the Reward Positivity

Causal Dissociation of Value Contributions to the Reward Positivity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05443256
Enrollment
9
Registered
2022-07-05
Start date
2022-08-01
Completion date
2024-10-17
Last updated
2024-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anhedonia

Brief summary

The aim of this proposal is to demonstrate that stimulation of different brain regions differently affects the electroencephalographic feature known as the Reward Positivity (RewP).

Detailed description

The aim of this proposal is to demonstrate that stimulation of different brain regions differently affects the electroencephalographic feature known as the Reward Positivity (RewP). The RewP is a sensitive and specific biomarker of reward receipt. This proposal will advance a causal test of the hypothesis that there are two major sources of variance that contribute to this brain response: a dorsal midline contribution to information encoding and a ventral midline contribution that is modulated by affect. Together, these findings will reveal how the RewP acts to blend multiple aspects of value together in the service of motivated learning. The objective of this proposal is to gather pilot data to demonstrate the feasibility of using transcranial magnetic stimulation (TMS) to perturb idiosyncratically-defined (fMRI-based) dorsal or ventral targets in order to causally test the hypothesis that these different sources contribute different types of variance to the RewP. TMS double cone deep coil stimulation should diminish +RPE encoding in the RewP when compared to sham. TMS Figure-8 coil stimulation should diminish affective modulation of RewP amplitude when compared to sham.

Interventions

DEVICETranscranial Magnetic Stimulation

Figure 8 coil stimulation

Sponsors

University of New Mexico
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Intervention model description

Two separate arms of study

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

• Men or women aged 18-30

Exclusion criteria

* Participants unwilling or unable to give informed consent * Presence of other known medical or psychiatric comorbidity that in the investigator's opinion would compromise participation in the study * MEG/MRI contraindications * History of psychosis * Not fluent in English

Design outcomes

Primary

MeasureTime frameDescription
Reward PositivityDuring interventionEEG Amplitude 200-400 ms following reward receipt

Countries

United States

Participant flow

Participants by arm

ArmCount
dlPFC Stimulation
To stimulate fMRI-informed individualized targets in dlPFC to diminish affective modulation of the RewP. Based on our working hypothesis, TMS Figure-8 coil stimulation should diminish affective modulation of RewP amplitude when compared to sham. Transcranial Magnetic Stimulation: Figure 8 coil stimulation
4
dmPFC Stimulation
To stimulate individualized targets in dmPFC to alter affective modulation of the RewP. Based on our working hypothesis, TMS Deep Cone stimulation should boost learning-related modulation of RewP amplitude when compared to sham. Transcranial Magnetic Stimulation: Deep Cone stimulation
4
Total8

Baseline characteristics

CharacteristicdlPFC StimulationdmPFC StimulationTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
4 Participants4 Participants8 Participants
Age, Continuous25.75 years
STANDARD_DEVIATION 5.12
29.75 years
STANDARD_DEVIATION 3.77
27.75 years
STANDARD_DEVIATION 4.68
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants1 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
4 Participants3 Participants7 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
1 Participants0 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants2 Participants2 Participants
Race (NIH/OMB)
White
3 Participants2 Participants5 Participants
Region of Enrollment
United States
4 Participants4 Participants8 Participants
Sex: Female, Male
Female
3 Participants0 Participants3 Participants
Sex: Female, Male
Male
1 Participants4 Participants5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 50 / 4
other
Total, other adverse events
0 / 50 / 4
serious
Total, serious adverse events
0 / 50 / 4

Outcome results

Primary

Reward Positivity

EEG Amplitude 200-400 ms following reward receipt

Time frame: During intervention

ArmMeasureValue (MEAN)Dispersion
dlPFC StimulationReward Positivity2.21 femtoteslasStandard Deviation 1.24
dmPFC StimulationReward Positivity.29 femtoteslasStandard Deviation 1.47

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026